Management After Thrombolysis for Acute Ischemic Stroke
Admit the patient to an intensive care or stroke unit immediately after thrombolysis for intensive monitoring, with specific blood pressure targets, neurological assessments every 15 minutes for the first 2 hours, and delay antiplatelet therapy for 24 hours until follow-up imaging is obtained. 1
Immediate Post-Thrombolysis Monitoring Protocol
Location of Care
- Admit to ICU or stroke unit for close monitoring 1
- Approximately 21% of patients will require true ICU-level interventions beyond monitoring 2
- Patients on antithrombotic therapy pre-admission or with higher NIHSS scores are at increased risk for ICU-level complications 2
Blood Pressure Management
Critical BP targets must be maintained:
- Keep BP ≤180/105 mm Hg for 24 hours after thrombolysis 1
Monitoring frequency:
- Every 15 minutes during and for 2 hours after alteplase infusion
- Every 30 minutes for the next 6 hours
- Hourly until 24 hours post-treatment 1
If systolic BP 180-230 mm Hg or diastolic BP 105-120 mm Hg, use: 1
- Labetalol 10 mg IV followed by continuous infusion 2-8 mg/min, OR
- Nicardipine 5 mg/h IV, titrate by 2.5 mg/h every 5-15 minutes (maximum 15 mg/h), OR
- Clevidipine 1-2 mg/h IV, titrate by doubling dose every 2-5 minutes (maximum 21 mg/h)
If diastolic BP >140 mm Hg: Consider IV sodium nitroprusside 1
Neurological Monitoring
Perform neurological assessments: 1
- Every 15 minutes for 2 hours
- Every 30 minutes for 6 hours
- Hourly until 24 hours after treatment
If patient develops severe headache, acute hypertension, nausea, vomiting, or worsening neurological examination:
- Discontinue alteplase infusion immediately (if still running)
- Obtain emergency head CT scan 1
Management of Symptomatic Intracranial Hemorrhage
If symptomatic ICH occurs within 24 hours: 1
- Stop alteplase infusion immediately
- Obtain labs: CBC, PT/INR, aPTT, fibrinogen level, type and cross-match
- Emergency noncontrast head CT
- Administer reversal agents:
- Cryoprecipitate 10 units IV over 10-30 minutes (administer additional dose if fibrinogen <200 mg/dL)
- Tranexamic acid 1000 mg IV over 10 minutes OR ε-aminocaproic acid 4-5 g over 1 hour, then 1 g IV until bleeding controlled
- Consult hematology and neurosurgery
- Supportive care: BP management, ICP control, temperature and glucose control
Antiplatelet and Anticoagulation Management
Timing of Antiplatelet Therapy
Do NOT start aspirin or other antiplatelet agents for 24 hours after thrombolysis 1, 3
This is a critical safety measure. Recent meta-analysis shows early antiplatelet therapy (within 24 hours) may increase symptomatic ICH risk (OR 1.68, though not statistically significant) without clear functional benefit 4. The 2018 AHA/ASA guidelines explicitly state to delay antiplatelet therapy until 24-hour follow-up imaging is obtained 1.
After 24 Hours
- Aspirin 160-325 mg can be initiated after follow-up imaging confirms no hemorrhagic transformation 3, 5
Anticoagulation
- Delay anticoagulants until 24-hour follow-up imaging 1
- Decision to start anticoagulation depends on stroke size, hemorrhagic transformation risk, and cardioembolic risk 3
Follow-Up Imaging
Obtain CT or MRI at 24 hours after thrombolysis before starting any antithrombotic therapy 1, 5
This imaging is mandatory to:
- Detect hemorrhagic transformation
- Guide antiplatelet/anticoagulation decisions
- Assess infarct evolution
Procedural Precautions
Delay placement of: 1
- Nasogastric tubes
- Indwelling bladder catheters
- Intra-arterial pressure catheters
Only place these if the patient cannot be safely managed without them, as they increase bleeding risk in the first 24 hours.
Temperature Management
Identify and treat sources of hyperthermia (temperature >38°C) 1
Fever worsens outcomes in acute stroke and should be aggressively managed.
Key Pitfalls to Avoid
Do not observe patients after IV thrombolysis to assess clinical response before pursuing endovascular therapy if indicated - this delays definitive treatment and worsens outcomes 6
Do not routinely start antiplatelet therapy early - the 24-hour delay is evidence-based for safety 1, 4
Do not undertarget BP control - maintaining BP ≤180/105 mm Hg is critical to prevent hemorrhagic transformation 1
Do not skip 24-hour imaging - this is mandatory before starting antithrombotic therapy 1